Kobayashi Pharmaceutical Co., Ltd.

Kobayashi Pharmaceutical Co., Ltd.

KBYPF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.93B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Kobayashi Pharmaceutical Co., Ltd.Kobayashi Pharmaceutical Co., Ltd.114.41.49%2%--
$18.97

Current Fair Value

51.9% downside

Overvalued by 51.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.93 Billion
Enterprise Value$-46,383,854,787.00
Annual dividend$0.66
Dividend yield1.49%
Earnings per Share$49.19
Beta0.25
Outstanding Shares74,338,617

Return

Return on Equity2.19%ROE
Return on Assets1.84%
Return on Invested Capital5.36%

Valuation & Multiples

P/E Ratio114.4P/E Ratio
PEG145.11PEG
Price to Sales0.02Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue2.84
Enterprise Value to EBIT41.46
Enterprise Value to Net Income-11
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 10, 2026
EPS
$0.56
Est. $0.41
Revenue
$271.55 M
Est. $286.70 M

Next Earnings Call

Expected Date
February 16, 2027
EPS Estimate
$0.27
Consensus analyst estimate
Revenue Estimate
$350.67 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Kobayashi Pharmaceutical Co., Ltd.

3,731 employees
CEO: Norikazu Toyoda

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and international...